Work

GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture

Year: 2018

Type: article

Study design: Observational Study

Source: European Urology Oncology

DOI: 10.1016/j.euo.2018.08.003

Authors: Renu Jeyapala, Andrea J. Savio, Ekaterina Olkhov-Mitsel, Shivani Kamdar, Fang Zhao, Carmelle Cuizon, Richard S.C. Liu, Alex Zlotta, Neil Fleshner, Theodorus van der Kwast, Bharati Bapat

Institutions: Mount Sinai Hospital, University of Toronto, Lunenfeld-Tanenbaum Research Institute, University Health Network

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Prostate Cancer Canada

Award: G1770119559

OpenAlex ID: W2889240474

FWCI: 0.604

Cites: 27

Cited by: 13

Related to: 10